AU Stock MarketDetailed Quotes
OSL OncoSil Medical Ltd
- 0.014
- +0.001+7.69%
20min DelayNot Open Oct 4 16:00 AET
52.98MMarket Cap-2333P/E (Static)
0.014High0.013Low4.04MVolume0.014Open0.013Pre Close56.50KTurnover0.01552wk High0.13%Turnover Ratio3.78BShares0.00452wk Low-0.006EPS TTM45.34MFloat Cap0.270Historical HighLossP/E (Static)3.24BShs Float0.004Historical Low-0.006EPS LYR7.69%Amplitude--Dividend TTM14.00P/B1Lot Size--Div YieldTTM
About OncoSil Medical Ltd Company
OncoSil Medical Ltd is an Australian based medical device company focused on localized radiation treatments for patients with pancreatic and bile duct cancer. The product includes OncoSil, a silicon and phosphorus (p32) beta emitter radiation therapy for the treatment of pancreatic cancer.
Company Profile
SymbolOSL
Company NameOncoSil Medical Ltd
Founded2005
MarketASX
Employees2
Fiscal Year Ends06-30
Address7 Eden Park Drive Macquarie Park
CitySydney
CountryAustralia
Zip Code2113
Phone+61 289359629
Websitehttps://www.oncosil.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- Nigel Lange
- Executive Director, Chief Executive Officer and Managing Director
- --
- Christian Dal Cin
- Chief Financial Officer
- --
- Dr. Jon Bell
- Chief Medical Officer
- --
- Douglas Cubbin
- Non-Executive Chairman of the Board
- --
- Dr Gabriel Liberatore
- Non-Executive Director
- --
- David Turner
- Global Head of Medical Affairs
- --
- Renzo DiCarlo
- Head of Transformation
- --
- Henk Tissing
- Global Head of Clinical Affairs
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data